课题基金 / 基金详情

Prevention of Cancer by Coriolus versicolor Mushroom

Prevention of Cancer by Coriolus versicolor Mushroom
云芝预防癌症
批准号:
6738190
负责人:
BELA TOTH
金额:
$22.05万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-15 至 2006-12-31

项目摘要

项目成果

BELA TOTH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Protein-bound polysaccharide K (PSK), a hot water extract from the fruiting body and mycelia of the Coriolus versicolor (CV) mushroom, has significant adjuvant activity in combination with oral fluorouracil chemotherapy for the treatment of gastric cancer and is approved for this indication in Japan. Recently, hot water extracts from the CV mushroom have been used as nutritional supplements by cancer patients in the US. Given the extensive use of these supplements, comparative studies into the bioactivity of the clinical (PSK) and nutritional supplement (VPS) preparations are warranted and we propose to compare their tumor preventative, and therapeutic activities, as well as extend our understanding of their mechanism of action based on immune augmentation. This proposal will address the hypothesis that the oral administration of PSK and VPS results in immunomodulatory activity and preventative and therapeutic activity in mice for colorectal cancer. This hypothesis will be tested using two autochthonous tumor models: 1,2-dimethylhydrazine (DMH) induced colorectal tumors and the Apcmin transgenic model of gastrointestinal polyps and adenomas. Our long-term objective is to initiate clinical studies in colorectal cancer, if warranted by these studies, using VPS and the immune surrogates identified by this proposal to support the phase I dose-finding protocols. Three Specific Aims are proposed to test our hypothesis: 1: Determine and compare the preventative and therapeutic activity of PSK and VPS for DMH induced preneoplastic lesions, adenomas and adenocarcinomas of the large intestine in mice. 2: Determine and compare the immune augmenting properties of PSK and VPS and correlate these parameters with tumor preventative and therapeutic activity. 3: Study the preventative and therapeutic activity of PSK and VPS activity in an Apc transgenic model of intestinal polyp and adenoma formation and its association with immune augmentation.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Lack of prevention of large intestinal cancer by VPS, an extract of Coriolus versicolor mushroom.
缺乏VPS(云芝蘑菇提取物)对大肠癌的预防作用。
DOI: --
发表时间: 2005
期刊: In vivo (Athens, Greece)
影响因子: --
作者: [Coles,Melissa, Toth,Bela]
通讯作者: Toth,Bela
Inhibition of large intestinal cancers by celecoxib using a serial sacrifice technique.
使用连续牺牲技术通过塞来昔布抑制大肠癌。
DOI: --
发表时间: 2006
期刊: In vivo (Athens, Greece)
影响因子: --
作者: [Toth,Bela, Coles,Melissa]
通讯作者: Coles,Melissa
DOI: --
发表时间: 2005
期刊: In vivo (Athens, Greece)
影响因子: --
作者: [Coles,Melissa, Toth,Bela]
通讯作者: Toth,Bela
Effects of VPS extract of Coriolus versicolor on cancer of the large intestine using a serial sacrifice technique.
使用连续牺牲技术研究云芝 VPS 提取物对大肠癌的影响。
DOI: --
发表时间: 2006
期刊: In vivo (Athens, Greece)
影响因子: --
作者: [Toth,Bela, Coles,Melissa, Lynch,James]
通讯作者: Lynch,James
Prevention of Cancer by Coriolus versicolor Mushroom
FALSE MOREL HYDRAZINES: CARCINOGENESIS AND CHEMISTRY
FALSE MOREL HYDRAZINES: CARCINOGENESIS AND CHEMISTRY
FALSE MOREL HYDRAZINES--CARCINOGENESIS AND CHEMISTRY
国内基金
海外基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
  • 批准号:
    82372007
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    谢文晖
  • 依托单位:
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 项目类别:
    专项基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2008
  • 负责人:
    焦宇飞
  • 依托单位: